Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Brilacidin Tetrahydrochloride
2. N4,n6-bis(3-((5-(carbamimidoylamino)pentanoyl)amino(-2-((3r)-pyrrolidin-3-yloxy)-5-(trifluoromethyl)phenyl)pyrimidine-4,6-dicarboxamide
3. Pmx 30063
4. Pmx-30063
5. Pmx-30063 Free Base
6. Pmx30063
7. Pmx30063 Free Base
1. 1224095-98-0
2. Brilacidin [usan]
3. Pmx30063 Free Base
4. Pmx-30063 Free Base
5. Brilacidin (usan)
6. I1679x069h
7. 4,6-pyrimidinedicarboxamide, N4,n6-bis(3-((5-((aminoiminomethyl)amino)-1-oxopentyl)amino)-2-((3r)-3-pyrrolidinyloxy)-5-(trifluoromethyl)phenyl)-
8. N4,n6-bis(3-(5-guanidinopentanamido)-2-(((r)-pyrrolidin-3-yl)oxy)-5-(trifluoromethyl)phenyl)pyrimidine-4,6-dicarboxamide
9. Brilacidin [usan:inn]
10. Unii-i1679x069h
11. Brilacidin [inn]
12. Brilacidin [who-dd]
13. Schembl2878543
14. Chembl2219413
15. Dtxsid90153594
16. Glxc-25591
17. Cs-6677
18. Db12997
19. Hy-19892
20. D10414
21. Q15408420
22. 4-n,6-n-bis[3-[5-(diaminomethylideneamino)pentanoylamino]-2-[(3r)-pyrrolidin-3-yl]oxy-5-(trifluoromethyl)phenyl]pyrimidine-4,6-dicarboxamide
23. N,n'-bis(3-((5-(carbamimidoylamino)pentanoyl)amino(-2-((3r)-pyrrolidin-3-yloxy)-5-(trifluoromethyl)phenyl)pyrimidine-4,6-dicarboxamide
24. N,n'-bis(3-((5-(carbamimidoylamino)pentanoyl)amino)-2-((3r)-pyrrolidin-3-yloxy)-5-(trifluoromethyl)phenyl)pyrimidine-4,6-dicarboxamide
| Molecular Weight | 936.9 g/mol |
|---|---|
| Molecular Formula | C40H50F6N14O6 |
| XLogP3 | 0.3 |
| Hydrogen Bond Donor Count | 10 |
| Hydrogen Bond Acceptor Count | 18 |
| Rotatable Bond Count | 20 |
| Exact Mass | 936.39419434 g/mol |
| Monoisotopic Mass | 936.39419434 g/mol |
| Topological Polar Surface Area | 314 Ų |
| Heavy Atom Count | 66 |
| Formal Charge | 0 |
| Complexity | 1560 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Anti-Infective Agents
Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. (See all compounds classified as Anti-Infective Agents.)
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
STOCK RECAP #PipelineProspector
NEWS #PharmaBuzz
ABOUT THIS PAGE
A Brilacidin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Brilacidin, including repackagers and relabelers. The FDA regulates Brilacidin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Brilacidin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Brilacidin supplier is an individual or a company that provides Brilacidin active pharmaceutical ingredient (API) or Brilacidin finished formulations upon request. The Brilacidin suppliers may include Brilacidin API manufacturers, exporters, distributors and traders.
Brilacidin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Brilacidin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Brilacidin GMP manufacturer or Brilacidin GMP API supplier for your needs.
A Brilacidin CoA (Certificate of Analysis) is a formal document that attests to Brilacidin's compliance with Brilacidin specifications and serves as a tool for batch-level quality control.
Brilacidin CoA mostly includes findings from lab analyses of a specific batch. For each Brilacidin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Brilacidin may be tested according to a variety of international standards, such as European Pharmacopoeia (Brilacidin EP), Brilacidin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Brilacidin USP).
LOOKING FOR A SUPPLIER?
